Clinical Trial

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

Study acronym: ESMONOL
Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated March 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate esmolol's perfusion impact during induction and maintenance of general anesthesia, using Nociception-Level-guided control of nociception, in adult patients undergoing laparoscopic and lower abdominal surgery, on intraoperative remifentanil consumption and postoperative pain in the Post-Anesthesia Care Unit.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06291363
Lead Sponsor Ciusss de L'Est de l'Île de Montréal
Conditions Opioid Use, Unspecified, Anesthesia, Nociceptive Pain
Enrollment 64 participants
Start Date 2024-04-16
Primary Completion 2025-03-03 (estimated)
Study Completion 2025-03-04 (estimated)
Updated on ClinicalTrials.gov 2024-07-16